- PREVENTABLE awarded by National Institutes of Health 2019 - 2027
- PREVENTABLE Trial Partnership and Meeting Support awarded by Alzheimer's Association 2024 - 2025
- Nanna, Michael G., Daniel Wojdyla, Eric D. Peterson, Ann Marie Navar, Jeff D. Williamson, Lisandro D. Colantonio, Stephen Y. Wang, et al. “Development and Validation of Models to Estimate the Incident Risk of Cognitive Impairment and Atherosclerotic Cardiovascular Disease in Older Adults.” J Am Heart Assoc 14, no. 11 (June 3, 2025): e038949. https://doi.org/10.1161/JAHA.124.038949.
- Peterson, Benjamin, Ajar Kochar, Rebecca Young, Balim Senman, Jennifer Rymer, Daniel Wojdyla, Ariela R. Orkaby, et al. “Effect of Frailty on In-Hospital Mortality and Complications of PCI: An NCDR Registry Report.” Journal of the American College of Cardiology 85, no. 24 (June 2025): 2416–20. https://doi.org/10.1016/j.jacc.2025.04.027.
- Jou, Stephanie, Laura P. Gelfman, Karen P. Alexander, R Sean Morrison, Deepak L. Bhatt, Alan Moskowitz, Emilia Bagiella, et al. “Clinical practice patterns among older multimorbid adults presenting with suspected ischemic symptoms: A multi-center survey.” Am Heart J Plus 52 (April 2025): 100517. https://doi.org/10.1016/j.ahjo.2025.100517.
- Sidhu, Mandeep S., Karen P. Alexander, Zhen Huang, Sean M. O’Brien, Bernard R. Chaitman, Gregg W. Stone, Jonathan D. Newman, et al. “Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial.” In Am Heart J, 248:72–83, 2022. https://doi.org/10.1016/j.ahj.2022.01.017.
- Guimaraes, Patricia, Renato D. Lopes, Daniel Wojdyla, John H. Alexander, Shaun G. Goodman, Ronald Aronson, Sigrun Halvorsen, et al. “Antithrombotic Strategies According to Age in Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the Augustus Trial.” In CIRCULATION, Vol. 144, 2021.
- Rasmussen, P. V., M. L. Hansen, G. Gislason, J. Pallisgaard, M. Ruwald, C. B. Granger, R. D. Lopes, K. P. Alexander, S. M. Al-Khatib, and F. Dalgaard. “Older patients with atrial fibrillation and comorbidities are less likely to be treated with oral anticoagulation: insights from a nationwide study.” In EUROPEAN HEART JOURNAL, 40:2978–2978. OXFORD UNIV PRESS, 2019.
Patient Reviews
Patient comments are gathered from our Press Ganey Patient Survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy